INTRODUCTION
Diabetic nephropathy (DN) has been widely recognized as a common complication of type 2 diabetes mellitus (T2D), which may further progress into end-stage renal disease and premature mortality. [1] Oxidative stress and increased inflammation are considered as key determinants of DN. [2] [3] [4] Due to increased reactive oxygen species (ROS) and inflammatory cytokines production, glomerular filtration membrane becomes permeable for plasma proteins, resulting in albuminuria, a hallmark of early the tubular damage biomarkers has been observed at the early stage of DN, even in the absence of albuminuria, thus making them specific and sensitive markers of DN. [1] Retinol-binding protein 4 (RBP4) has been widely explored as adipokine, closely related to cardiometabolic indices. [8] [9] [10] [11] Furthermore, due to its low molecular weight (21 kDa) , it is freely filtered through the glomeruli and then almost completely reabsorbed in the proximal tubuls, which makes this protein as useful biomarker of tubular renal impairment. Namely, a significant rise of this biomarker has been observed in the end-stage renal disease, [12] which was decreased after kidney transplantation. [13] As well, serum RBP4 levels were associated with estimated glomerular filtration rate (eGFR), as well as positively correlated with changes in serum creatinine, confirming its association with renal function. [13] In order to get better insight into the pathophysiological mechanisms of renal function decline, we aimed to examine markers of glomerular damage (i.e., urinary albumin), markers of tubular damage (i.e., serum RBP4), and inflammation markers (i.e., serum high sensitivity C-reactive protein level [hsCRP] ) in patients with T2D. Furthermore, we aimed to investigate if urinary albumin is superior than tubular damage, inflammation, and some traditional markers in predicting renal function impairment in the cohort of patients with T2D.
MATERIALS AND METHODS

Study population
The current cross-sectional study derived from our previous works investigating the utility of cardiometabolic, inflammation, and oxidative stress markers in individuals with T2D. [14] [15] [16] [17] The study enrolled a total of 106 patients with T2D (mean age 64.9 ± 6.6 years, of them 61.3% females). All patients with T2D were consecutively recruited by the endocrinologist in the Center for Laboratory Diagnostics of the Primary Health Care Center in Podgorica, Montenegro, for their regular checkup in a period from October 2012 to May 2016.
Participants that were included in the study were patients with T2D without acute inflammatory disease, or urinary infection and/or hematuria. Diabetes cases were defined as described in our previous reports. [14] [15] [16] [17] Exclusion criteria from the current investigation were participants with diabetes mellitus type 1, with eGFR <15 mL/min/1.73 m 2 , patients on chronic dialysis, with kidney transplantation, renal disease other than DN, diseases other than diabetes which induce proteinuria (e.g., vasculitis and amyloidosis), hsCRP >10 mg/L, those with a recent (6 months) history of acute myocardial infarction or stroke, carcinoma, pregnancy, and with history of alcohol abuse (i.e., ethanol consumption >20 g/day). All the examinees signed informed consent. Ethical Committee of Primary Health Care Center in Podgorica, Montenegro (number 317/2) approved the study protocol, and the investigation was carried out in compliance with the Declaration of Helsinki.
Anthropometric measurements
Basic anthropometric measurements were obtained, as described previously. [18] Biochemical analyses After at least 8 h of an overnight fasting, cubital venous sample blood (10 mL) was collected from each participant for biochemical analyses (fasting glucose, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides [TG] , creatinine, glycated hemoglobin [HbA1c], hsCRP, and RBP4 levels), as described elsewhere. [14, 18] Examinees were requested to provide two blood samples, one for whole blood in K 2 EDTA for HbA1c determination and the other for serum extraction. Patients were also asked to provide 24 h urine sample. Rate of urinary albumin excretion (UAE) <30 mg/24 h was considered as normoalbuminuria; UAE within the range 30-300 mg/24 h was considered as microalbuminuria, while UAE rate ≥300 mg/24 h was regarded as macroalbuminuria. All the examinees were instructed on how to collect 24 h urine and asked to store the urine on cold (4°C).
Blood pressure was measured as described previously. [18] Glomerular filtration rate was estimated by using creatinine in the Modification of Diet in Renal Disease Study equation (eGFR MDRD ). [14] Renal function decline is defined as eGFR MDRD <60 mL/min/1.73 m 2 . Logistic regression analysis was used to elucidate the association between eGFR MDRD and other clinical parameters. The dependent variable was eGFR MDRD coded as 0 for eGFR MDRD <60 mL/min/1.73 m² and coded as 1 for eGFR MDRD ≥60 mL/min/1.73 m².
Statistical analysis
Since we aimed to get better insight into the pathophysiological mechanisms of renal function decline in patients with T2D, we included marker of glomerular damage (i.e., UAE), marker of tubular damage (i.e., serum RBP4), and inflammation marker (i.e., serum hsCRP). In addition, we included traditional risk factors such as body mass index (BMI), HbA1c, and TG. Therefore, independent variables were BMI, HbA1c, TG, hsCRP, RBP4, and UAE (all continuous). Those continuous variables which had P < 0.05 when testing bivariate correlations with eGFR MDRD were included in univariate and further multivariate logistic regression analysis. Because they entered the equation for GFR calculation, age and creatinine were excluded from logistic regression analysis. To examine tested independent variables, independent predictions on eGFR MDRD multivariate logistic regression analysis were employed. The explained variation in eGFR MDRD was given by Nagelkerke R 2 value. Receiver operating characteristic (ROC) curve analysis was used to test the diagnostic performance of each independent variable and the Model to discriminate patients that suffered from renal function decline from those that did not have it. Differences between curve areas for UAE and the Model were also tested.
Data are shown as mean ± standard deviation for normally distributed continuous variables, as geometrical mean (95% confidence interval [CI]) for log-normally distributed variables, median (interquartile range), and as absolute frequencies for categorical variables. [19] All tests were considered significant at the probability level P < 0.05. Table 1 shows the biochemical parameters in diabetic patients with renal decline (eGFR MDRD <60 mL/min/1.73 m²) and those that did not have it (eGFR MDRD ≥60 mL/min/1.73 m²). Unequal distribution of patients taking antihyperglycemic or insulin therapies was established among groups. Patients with eGFR MDRD ≥60 mL/min/1.73 m² were older and had higher BMI than those with eGFR MDRD <60 mL/min/1.73 m². Furthermore, HbA1c, TG, creatinine, RBP4, and UEA concentrations were significantly higher among patients with eGFR MDRD <60 mL/min/1.73 m². No other significant differences in clinical parameters were present between these two groups [ Table 1 ].
RESULTS
Spearman's correlation analyses were performed to test the associations between eGFR MDRD and other clinical parameters. Estimated GFR MDRD was significantly negatively correlated with age, TG, hsCRP, creatinine, RBP4, UAE, and positively correlated with BMI [ Table 2 ]. Table 3 summarizes results of logistic regression analysis applied to examine the associations of parameters significantly correlated with eGFR MDRD such as BMI, HBA1c, TG, hsCRP, RBP4, and UAE as independent variables (predictors) on eGFR MDRD as dependent variable. Age and creatinine were excluded from further analysis because they were used for eGFR MDRD calculation. Predictors were unadjusted and adjusted for other parameters and tested by univariate and multivariate analysis, respectively. In order to test if RBP4 together with other routinely determined parameters could be as good indicator of renal function as UAE, the latter was tested only in univariate analysis and it did not enter the Model like all the other parameters. HsCRP, RBP4, and UAE showed significant odds ratio (OR) in univariate logistic regression [ Table 3 ]. As hsCRP rose for 1 mg/L, RBP for 1 mg/L, and UAE for 1 mg/24 h, probability for eGFR MDRD ≥60 mL/min/1.73 m² decreased for 14.3%, 11.2%, and 0.4%, respectively. Nagelkerke R 2 showed that each predictor in univariate analysis such as hsCRP, RBP4, and UAE could explain the variation in eGFR MDRD by 5.4%, 58.4%, and 55.9%, respectively. Multivariate logistic regression analysis showed that only hsCRP and RBP4 kept independent prediction on eGFR MDRD [Model, Table 3 ] . As hsCRP rose for 1 mg/L and RBP4 for 1 mg/L, the probability for eGFR MDRD ≥60 mL/min/1.73 m² decreased for 24.6% and 12.7%, respectively. Adjusted R 2 for the Model was 0.733, which means that even 73.3% of variation in eGFR MDRD could be explained with this Model [ Table 3 ].
ROC analysis was used to discriminate patients with renal function decline from those who did not have it [ Table 4 ]. The calculated AUC for BMI, HbA1c, TG, and hsCRP were ranking from 0.600 to 0.700 indicated that the clinical accuracy of each diagnostic parameter was low according to Swets. [20] On the contrary to these single predictors, RBP4 and UAE as single diagnostic parameters of renal impairment showed excellent clinical accuracy (AUC = 0.900 and AUC = 0.940, respectively) [ Table 4 ]. Furthermore, the same was established for the Model which included BMI, HbA1c, TG, hsCRP, and RBP4 (continuous variables). The calculated AUC for the Model was 0.932 which suggested statistically same accuracy as UAE, when UAE was used as a single parameter [ Figure 1] . Accordingly, the difference between areas was 0.008, SE = 0.026, 95% CI (−0.043-0.059) and P = 0.759. As well, the Model had higher sensitivity and specificity (92% and 90%, respectively) than single predictors (i.e., RBP4 and UAE) [ Table 4 and Figure 1 ].
DISCUSSION
The main finding of the current study is that tubular damage marker such as serum RBP4 as single diagnostic parameter of renal impairment showed excellent clinical accuracy, just like UAE (AUC = 0.900 and AUC = 0.940, respectively) [ Table 4 ]. Furthermore, we have shown that serum RBP4, hsCRP and some routinely determined parameters, could be as good indicators of renal function decline (defined as eGFR <60 mL/min/1.73 m 2 ) as UAE.
Even though albuminuria has been considered as the gold standard biomarker for DN onset and progression, it lacks specificity for diagnosing disease progression (i.e., when UAE is 30-300 mg/24 h), as well as sensitivity, since DN can often progress even without albuminuria. [7, 21] Hence, the quest for a better biomarkers with high sensitivity and specificity for early detection of DN is needed.
Since renal proximal tubular injury may occur before a reduction of GFR, we examined the utility of tubular biomarker, such as serum RBP4, in comparison with glomerular biomarkers, such as urinary albumin. Previous study by Mahfouz et al. [22] showed that RBP4 was more specific (90% specificity) than albumin-to-creatinine ratio for discriminating DN onset (72% specificity), suggesting that RBP4 may serve as an efficient diagnostic tool for clinical monitoring of kidney disease progression. However, our study reported that both of those biomarkers had excellent clinical accuracy for eGFR decline prediction. Several previous studies also reported elevated serum RBP4 levels in kidney disease [12, 13, 23, 24] Data are presented as correlation coefficient Rho (ρ). BMI=Body mass index; HbA1c=Glycated hemoglobin; TC=Total cholesterol; HDL-c=High-density lipoprotein cholesterol; LDL-c=Low-density lipoprotein cholesterol; TG=Triglycerides; hsCRP=High-sensitivity C-reactive protein; RBP4=Retinol-binding protein 4; UAE=Urinary albumin excretion rate; eGFR MDRD =Estimated glomerular filtration rate in the modification of diet in renal disease study equation
but did not make a comparison between those two biomarkers.
Oxidative stress and increased inflammation play a key role in DN development. [1, 2] Chronic hyperglycemia enhances ROS production which causes the damage of the glomerular filtration barrier integrity, leading to albumin leakage, which can with ROS in the tubular ultrafiltrate further activate a variety of aberrant signaling pathways to cause overall renal function deterioration. [1] Increased activation of different signaling mediators such as transcription factors, inflammatory agents, and cytokines can compromise renal hemodynamics and increase glomerular extracellular matrix accumulation, thus further leading to interstitial fibrosis and glomerulosclerosis to eventual end-stage renal disease. [25] Indeed, individuals with DN have increased low-grade inflammation for years before renal impairment can become clinically detectable. [21] Multivariate logistic regression analysis in the current study showed that both hsCRP and RBP4 kept independent prediction on eGFR MDRD [Model, Table 3 ] . As hsCRP rose for 1 mg/L and RBP4 for 1 mg/L, probability for eGFR MDRD ≥60 mL/min/1.73 m² decreased for 24.6% and 12.7%, respectively.
Pro-inflammatory cytokines are considered as determining factors in the development of microvascular diabetic complications, acting through nuclear transcription factor-kappa B (NF-κB) signaling hsCRP pathway. [26] In line with our results, previous studies also reported high hsCRP in patients with DN. [26, 27] Furthermore, earlier studies reported the utility of some other parameters such as cystatin C, for estimation of eGFR decline, suggesting its high diagnostic accuracy for screening of DN. [28] In our study, to seek for the panel of parameters that might display the best specificity and sensitivity for discrimination of patients with renal function decline from those who did not have it, ROC analysis was used [ Table 4 ]. Model which included RBP4, hsCRP, gender, BMI, HbA1c and TG, suggested statistically same accuracy as UAE, when UAE was used as a single parameter (AUC = 0.932 vs. AUC = 940, respectively; p for AUC diff erence = 0.759) [ Table 4 and Figure 1 ]. Of note, the Model had higher sensitivity and specificity (92% and 90%, respectively) than single predictors RBP4 and UAE [ Table 4 ], suggesting that other traditional markers should not be underestimated when examining diabetic kidney disease. [29, 30] The limitations of our study are cross-sectional design and small sample size. However, in addition to urinary albumin we examined a broad panel of biomarkers, such as marker of tubular damage but also inflammation and several wellknown traditional markers.
CONCLUSION
The novel finding of the current study is that even though that tubular damage marker such as serum RBP4 as single diagnostic parameter of renal impairment showed excellent clinical accuracy, just like UAE, a combination of markers of tubular damage, inflammation markers, and traditional markers has the higher sensitivity and specificity than urinary albumin alone. Given that the early prediction of the onset of renal function decline is of urgent need to prevent further possible complications, the quest for more biomarkers with higher sensitivity and specificity is of great clinical importance.
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